A new independent evaluation of court-ordered outpatient treatment in New York State casts serious doubt on the state's (and ...
3d
New clinical tool helps predict short-term risk of diabetes complications using routine health data
Researchers at the University of Maryland School of Medicine (UMSOM) have developed and validated a new risk calculator that ...
Fresh off a phase 3 win in biliary tract cancer, Akeso CEO Michelle Xia, Ph.D., is touting the PD-1xVEGF bispecific antibody ...
Regulatory flexibility can be exercised in rare disease without sacrificing rigor,” writes Mindy Leffler, whose son has ...
On June 24, 2026, the U.S. Food and Drug Administration (FDA) released a draft update to its 2019 draft guidance titled “Demonstrating ...
Arvinas, Inc. is upgraded to a Buy, underpinned by Veppanu’s FDA approval and a robust PROTAC platform. Learn more about ARVN ...
Ironwood Pharmaceuticals is a small-cap GI-focused biotech with strong LINZESS sales but looming patent expiry by 2029–2030.
A centuries-old heart drug costing less than ten cents a day could help keep heart-failure patients out of the hospital. New ...
When employers reduce their workforce to demographic boxes, Jewish identity largely disappears. Antisemitism, unfortunately, ...
New research indicates that people with diabetes may have a lower risk of developing ALS compared to those without diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results